Knight Initiative News

In this episode, we explore the fascinating neuroscience behind how children learn to read with Bruce McCandliss, director of the Stanford Educational Neuroscience Initiative.

Stanford researchers reviewed over 400 therapy evaluations and discovered a crucial mismatch: Mouse studies test disease prevention, while human trials test treatment of existing disease.

Stanford Medicine researchers explain how sleep influences our moods and the ‘bidirectional’ nature of that relationship — plus how we can repair broken slumber to improve our mental health.

Blood and cerebrospinal fluid markers tied to inflammation and metabolism sort some patients into subgroups, according to Knight Initiative researchers, a step toward predicting progression and tailoring care.

In which neuroscientist Dan Abrams shares the quest to understand how our brains are tuned for voices, and why this instinct fails to develop in children with autism.

The lab’s second crop of pilot awards will foster research in visual attention, the neurophysiology of exercise, and therapies for autism and mild cognitive impairment associated with aging.

Knight Initiative-funded research ran the gamut from chemistry to public health, but one theme brought it all together: Studying what makes the brain resilient will help more people live better lives.

In which addiction expert Keith Humphreys explains how neuroscience is reshaping our understanding of substance abuse—and why policy still hasn’t caught up.

Research in mice indicates that inhibiting the LRRK2 enzyme could stabilize patients with a type of Parkinson’s disease.

In which physician-scientist Marion Buckwalter shares the remarkable advances we've seen in stroke care in recent decades, thanks to long-standing national support for curiosity-driven research

Scientists in the lab of chemical engineer Monther Abu-Remaileh are uncovering the cellular functions that go awry in degenerative brain disorders and identifying therapies that could treat them.

In which anesthesiologist Martin Angst shares how studying the biology of recovery may reveal why some aging brains withstand stress while others quietly unravel.

Researchers supported by a Neuroscience:Translate grant from Wu Tsai Neuro have developed a new technology for removing blood clots that is more than twice as effective as current techniques.

A team at Stanford, supported by the Knight Initiative for Brain Resilience, is using the biology of recovery to uncover why some aging brains withstand stress while others quietly unravel.

In a favorite 2024 episode, we spoke with Jaimie Henderson, a Stanford neurosurgeon leading groundbreaking research in brain-machine interfaces.

In which Anthony Wagner and Beth Mormino share what they are learning from the Stanford Aging and Memory Study about the nature of healthy brain aging.

Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, according to research by Wu Tsai Neuro affiliate Michelle Monje and colleagues. They also identified compounds that could treat it.

Improving cells’ ability to sort and recycle components—including cholesterol—could lead to therapies for a wide range of neurodegenerative conditions.

Favour Nerrise, NeuroTech trainee and NeURO-CC mentor, is competing in Stanford’s inaugural 3-Minute Thesis competition on April 17 presenting research that uses at–home tech and artificial intelligence to spot brain disease.

A new analysis of a vaccination program in Wales by a Knight Initiative–supported team found that the shingles vaccine appeared to lower new dementia diagnoses by 20% — more than any other known intervention.